Forte Biosciences, Inc. (FBRX)
Aug 27, 2026 - FBRX was delisted (reason: acquired by ARGX)
76.99
0.00 (0.00%)
Inactive · Last trade price on Aug 26, 2026
Forte Biosciences Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Forte Biosciences stock has a consensus rating of "Hold" and an average price target of $73.8. The average 1-year stock price forecast is 4.14% lower than the current stock price, while the lowest is $61 (-20.77%) and the highest is $77 (+0.01%).
Price Target: $73.8 (-4.14%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Forte Biosciences stock from 5 stock analysts was "Hold". This means that analysts believed this stock was likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Reiterates $77 | Hold | Reiterates | $77 | +0.01% | Aug 13, 2026 |
| Brookline Capital Markets | Brookline Capital Markets | Hold Downgrades $77 | Hold | Downgrades | $77 | +0.01% | Jul 27, 2026 |
| Evercore ISI | Evercore ISI | Hold Downgrades $69 → $77 | Hold | Downgrades | $69 → $77 | +0.01% | Jul 27, 2026 |
| TD Cowen | TD Cowen | Hold Downgrades $77 | Hold | Downgrades | $77 | +0.01% | Jul 27, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $75 | Buy | Reiterates | $75 | -2.58% | Jul 10, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.93
from -4.71
EPS Next Year
-3.94
from -3.93
EPS and Forward PE are based on non-GAAP adjusted numbers.